An abstinence-oriented program for substance use disorders: Poorer outcome associated with opiate dependence

Canadian Journal of Psychiatry

Volumn 45, Issue 10, 2000, Pages 927-931

  Paraherakis, A ^a   Charney, D A ^a   Palacios Boix, J ^a   Gill, K ^a  

^a MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

Psychopathology; Substance dependence; Treatment outcome

Indexed keywords

ABSTINENCE; ADULT; ARTICLE; CANADA; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OPIATE ADDICTION; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 0034503121     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370004501009     Document Type: Article

References (25)

1. Effectiveness of treatment for drug abuse: An overview of the DARP research program
2. Overview of 1-year Follow-up in the Drag Abuse Treatment Outcome Study (DATOS)
3. Treatment retention and follow-up outcomes in the Drag Abuse Treatment Outcome Study (DATOS)
4. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS)
5. Length of stay, patient severity and treatment outcome: Sample data from the field of alcoholism
6. Perspectives of effective treatment for alcohol and drug disorders
7. Evaluating the effectiveness of addiction treatments reasonable expectations appropriate comparisons
8. Dropping out of substance abuse treatment: A clinically oriented review
9. Patient factors related to early attrition from an outpatient cocaine research clinic: A preliminary report
10. Predicting treatment retention among eocaine users
11. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services
12. A meta-analysis of predictors of continued drug use during and alter treatment for opiate addiction
13. Integration of treatment and posttreatment variables in predicting results of abstinence-based outpatient treatment after one year
14. Do substance abuse patients with more psychopathology receive more treatment?
15. Prognostic significance of psycbiatric disorders in treated opiate addicts
16. The impact of depression on the outcome of addictions treatment
17. The SCL-90-R: Administration, scoring and procedures manual II. Towson (MD)
18. Antisocial personality disorder. HIV risk behavior and retention in methadone maintenanee therapy
19. HIV infection and intravenous drug use: Critical issues in transmission dynamics, infection outcomes, and prevention
20. Role of drug-abuse treatment in limiting the spread of AIDS
21. Treatment of depressive syndromes in detoxified drug addicts: Use of methadone
22. Methadone maintenance in the treatment of opioid dependence: A current perspective